- Home
- SFM vs AXSM Comparison
SFM vs AXSM Comparison
Compare SFM & AXSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SFM | AXSM |
|---|---|---|
| Founded | 2002 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Food Chains | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.8B | 7.4B |
| IPO Year | 2013 | 2015 |
Fundamental Metrics
Financial Performance| Metric | SFM | AXSM |
|---|---|---|
| Price | $80.17 | $148.59 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 14 | 20 |
| Target Price | $138.64 | ★ $176.00 |
| AVG Volume (30 Days) | ★ 2.1M | 477.6K |
| Earning Date | 02-19-2026 | 02-17-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 49.03 | N/A |
| EPS | ★ 5.15 | N/A |
| Revenue | ★ $8,653,696,000.00 | $561,263,000.00 |
| Revenue This Year | $15.28 | $66.40 |
| Revenue Next Year | $9.87 | $56.13 |
| P/E Ratio | $15.67 | ★ N/A |
| Revenue Growth | 16.60 | ★ 65.83 |
| 52 Week Low | $75.75 | $75.56 |
| 52 Week High | $182.00 | $158.57 |
Technical Indicators
Market Signals| Indicator | SFM | AXSM |
|---|---|---|
| Relative Strength Index (RSI) | 43.60 | 50.89 |
| Support Level | $77.33 | $152.41 |
| Resistance Level | $81.96 | $158.56 |
| Average True Range (ATR) | 2.15 | 4.09 |
| MACD | 0.37 | -0.44 |
| Stochastic Oscillator | 45.84 | 29.93 |
Price Performance
Historical ComparisonAbout SFM Sprouts Farmers Market Inc.
Sprouts Farmers Market Inc offers a specialty grocery experience featuring an open layout with fresh produce at the heart of the store. Sprouts inspire wellness naturally with a carefully curated assortment products paired with purpose-driven people. The company continues to bring products made with lifestyle-friendly ingredients such as organic, plant-based, and gluten-free. It approximately has 407 stores in nearly 23 states. The Company has one operating segment that is healthy grocery stores.
About AXSM Axsome Therapeutics Inc.
Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products includes AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.